Assistant Professor, Medicine - Pulmonary and Critical Care Medicine, Stanford University Medical Center
Pulmonology
Dr. Roham T. Zamanian, MD
|
|
Give Review
Roham Zamanian practices Pulmonology. He researched medicine at University of California Irvine School of Medicine. University of California Irvine School of Medicine has a rank of 45 in research and a 62 in primary care He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Roham Zamanian is a published MD. He has 34 publications published. The most current publication "Addressing the Controversy of Estimating Pulmonary Arterial Pressure by Echocardiography." He is registered with Medicare.
Publications
- Leukotriene B4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension.
- Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.
- Single- vs double-lung transplantation in patients with Chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis since the implementation of lung alloca...
- Erythropoietin upregulation in Pulmonary arterial hypertension.
- WHOLE EXOME SEQUENCING REVEALS TOPBP1 AS A NOVEL GENE IN IDIOPATHIC Pulmonary ARTERIAL HYPERTENSION.
- Impact of insulin resistance on ventricular function in Pulmonary arterial hypertension.
- Relationship between Echocardiographic and Magnetic Resonance Derived Measures of Right Ventricular Size and Function in Patients with Pulmonary Hypertension.
- Septal Curvature Is Marker of Hemodynamic, Anatomical, and Electromechanical Ventricular Interdependence in Patients with Pulmonary Arterial Hypertension.
- Blocking macrophage leukotriene b4 prevents endothelial injury and reverses Pulmonary hypertension.
- Transplantation for idiopathic Pulmonary arterial hypertension: improvement in the lung allocation score era.
- A case of recurrent pericardial constriction presenting with severe Pulmonary hypertension.
- Circulating angiogenic modulatory factors predict survival and functional class in Pulmonary arterial hypertension.
- Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.
- Safety and Efficacy of Transition from Systemic Prostanoids to Inhaled Treprostinil in Pulmonary Arterial Hypertension.
- Diagnosis and management of Pulmonary hypertension associated with left ventricular diastolic dysfunction.
- Characteristics and Outcome following Hospitalization for Acute Right Heart Failure in Patients with Pulmonary Arterial Hypertension.
- Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.
- Design and validation of an endothelial progenitor cell capture chip and its application in patients with Pulmonary arterial hypertension.
- Incidence, correlates, and consequences of acute kidney injury in patients with Pulmonary arterial hypertension hospitalized with acute right-side heart failure.
- Disruption of the apelin-APJ system worsens hypoxia-induced Pulmonary hypertension.
- Characterization of connective tissue disease-associated Pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
- Right ventricular Failure: a novel era of targeted therapy.
- Epoprostenol-associated Pneumonitis: diagnostic use of a T-cell proliferation assay.
- Worldwide physician education and training in Pulmonary hypertension: Pulmonary vascular disease: the global perspective.
- PPARgamma activation: a potential treatment for Pulmonary hypertension.
- Angina associated with left main coronary artery compression in Pulmonary hypertension.
- Insulin resistance in Pulmonary arterial hypertension.
- Effectiveness and cost effectiveness of thrombolysis in patients with acute Pulmonary embolism.
- Surrogate and combined end points in Pulmonary arterial hypertension.
- Management strategies for patients with Pulmonary hypertension in the intensive care unit.
- CT angiography of Pulmonary artery aneurysms in Hughes-Stovin syndrome.
- Surgical and interventional therapies for Pulmonary arterial hypertension.
- Addressing the Controversy of Estimating Pulmonary Arterial Pressure by Echocardiography.
Schools
University of California At Irvine California College of Medicine amp Surgery
Uci Med Center
Stanford University Med Center
Procedures Preformed
- Continuous Positive Airway Pressure (CPAP)
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asthma
- Atelectasis
- View All
Doctors Specialties
- Pulmonology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Select PPO
- Access Plus Savenet
- Basic Exclusive PPO for Small Business
- Basic PPO
- Cigna
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- GEHA
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Medicaid
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
University of California Irvine -
University of California Irvine School of Medicine
Hospital
-
Stanford Health Care
Drug Facts
| NPI NUMBER | 1689601494 | |
| NPPES Provider LastName | ZAMANIAN | |
| NPPES Provider FirstName | ROHAM | |
| NPPES Provider ZIPCode | 943052200 | |
| NPPES Provider State | CA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 442.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1689601494 |
| Last Name Of The Provider | ZAMANIAN |
| First Name Of The Provider | ROHAM |
| View All |
Similar Doctors
|
|
Dr. Roland G. Nador, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Viswam S. Nair, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yon K. Sung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas A. Raffin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark R. Nicolls, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|